EyePoint, Inc. Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs
EyePoint, Inc. (EYPT) had Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs of $300.00 thousand as of 2019-04-01, per its 10-Q filed 2019-05-10.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts · last filed 2019-05-10
- 2019-04-01: Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs $300.00K.
| Period end | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs |
|---|---|
| 2019-04-01 | $300.00K 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |